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Abstract
Background:  Although age is an important factor in female fertility, not much date were focused on the
relationship between age and ovarian response and in vitro fertilization (IVF) outcome. However, the female
reproductive capacity varies with age.
Objective: To assess the impact of age on ovarian response and IVF outcome during controlled ovarian
hyperstimulation in women from Gaza Strip.
Methods: This prospective cohort study consisted of 75 women attending IVF at Al-Basma Fertility Center in Gaza
City. The number of oocytes and embryos were recorded for each female and the occurrence of pregnancy was
followed for three months. The obtained data were computer analyzed using SPSS statistical package version 18.
Results: The mean age of the study population was 29.2±5.9 years. The total number of oocytes was significantly
decreased with increasing age (F=3.932 and P=0.024).In this context Pearson correlation test exhibited negative
significant correlation between women age and the number of mature oocyte (r=-0.276, P=0.017). There was an
inverse relationship between age and ovarian response (F=6.773 and P=0.001), showing good response (9-16
oocytes) at mean age of 26.7±5.0 years. When related to women age, IVF outcome showed that the chance of
getting pregnant increased with decreased age (F=4.278 and p= 0.018).
Conclusion: The ovarian response and the chance of getting pregnancy were diminishing with ageing, implying
that maternal age should by consider during IVF program.
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Introduction
Controlled ovarian hyperstimulation (COH) refers to a regime
of fertility medication that used to stimulate the development
of multiple follicles of the ovaries in one single cycle, resulting
in superovulation. Controlled ovarian hyperstimulation for
in vitro fertilization (IVF) cycles is usually monitored by
serum estradiol levels and pelvic ultrasonography with two
purposes: (1) to obtain an adequate number of mature
oocytes, and (2) to prevent the risk of severe ovarian
hyperstimulation syndrome.1,2 However, maternal age is of
a particular concern prior to COH in the general practice of
IVF treatment.3,4
Female age is the single most important determinant of
spontaneous as well as treatment-related conception, with a
gradual decline in fertility especially after the age of 35
years.5,6,7,8 A putative cause of such decline in fertility was
attributed to diminished ovarian reserve which refers to the
number and quality of oocytes.9 Older women may be more
likely to be diagnosed with unexplained infertility and that
this is due to the negative effect of age on ovarian reserve.10
Nonetheless, the relationship between age and declining
reproductive capacity is highly variable.11,12
Although extensive research has been carried out globally
on IVF to achieve pregnancy,3,8,9 just recently two studies
have been conducted in Gaza Strip and published in this
regard entitled “Anti-mullerian hormone as a predictor of
ovarian reserve and ovarian response in IVF women from
Gaza strip”13 and “Serum estradiol level as a predictor of
ovarian response and pregnancy outcome during controlled
ovarian hyperstimulation in women from Gaza Strip”.14
However, there was no previous studies related age to COH
or even to the IVF outcome. Therefore, the present study is
the first one to assess the impact of age on ovarian response
and IVF outcome during COH in women from Gaza Strip.
Methods
This prospective cohort study consisted of 75 women
undergoing COH program and aged between 20-40 years
without history of other diseases. The subjects were recruited
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from Al-Basma fertility Center in Gaza City in the period
September 2011 to November 2011. Each patient gave
informed consent to participate in the study. The criteria for
inclusion were as follows: (i) age 20–40 years, (ii) regular
menstrual cycle, (iii) not on hormone therapy for three
months and (iv) have not been subject to surgical operation
in the reproductive system. This study was approved by the
Ethical Committee of the institution. All participants were
guaranteed confidentiality, and only the principal investigator
has full access to the data.
In Vitro Fertilization Protocol
There were two protocols used during ovarian
hyperstimulation, the first one is long protocol, which relies
on pre-stimulation pituitary down regulation using GnRH
agonists in daily intermittent or depot formulations. The
second one is short protocols using GnRH antagonist during
the late follicular phase of the stimulation cycle have been
utilized. Adding recombinant LH to recombinant FSH
protocols, when starting antagonists, as a strategy to increase
oocyte yield and improve pregnancy rates. Human chorionic
gonadotropin (hCG) was injected at a dose of 5000 or 10,000
IU. Oocyte retrieval for IVF was then typically scheduled for
30–34 hr thereafter. Then the fertilized oocyte was placed in
G1 media for 3-4 days then in G2 media before rewind. The
vaginal sonography was performed in the second day of the
menstrual cycle to assess the extent of the responsiveness
of the ovary. The number of oocytes and embryos were
recorded for each female and the occurrence of pregnancy
was followed for three months.
Statistical analyses
Simple distributions of the study variables and cross
tabulation were applied. One-way ANOVA test was used for
evaluating the relation between age and qualitative and
quantitative variables. Pearson correlation test was applied.
The results in all the above mentioned procedures were
accepted as statistically significant when the p-value was
less than 5% (p<0.05).
Results
The study population included 75 females who had seeking
in IVF at Al-Basma fertility Center in Gaza City, Gaza Strip.
The mean age was 29.2±5.9 years. Clinical data showed that
the majority of the interviewed woman 46 (61.3%) claimed
that their husbands were the main cause of infertility.  Around
half of population 38 (50.7%) had undergone repeated IVF.
The result of IVF was positive in 27 (36.0%) of the study
population.
As indicated in table I, the age was classified into three
categories: d”25, 26-35 and >35 years. The total number of
oocytes was significantly decreased with increasing age
registering means of 11.0±3.8, 9.3±5.7 and 5.8±5.6, at age
groups d”25, 26-35 and >35 years, respectively (F=3.932 and
P=0.024). This inverse relationship was exhibited in mature
oocytes and number of embryo , but the change in their
mean number among the different age groups was not
significant. Pearson correlation test exhibited negative
significant correlation between women age and the number
of mature oocytes (r=-0.276, P=0.017) figure (1).
Table-I
Age classes of the study population in relation to various types of oocytes and embryos (n=75)
Oocytes Age (year) F P-value
(<25) (n=20) ( 26- 35) (n=42) (> 35)(n=13)
Total number of oocytes 11.0±3.8 9.3±5.7 5.8±5.6 3.932 0.024
Mature oocytes 7.4±2.7 7.0±4.2 4.5±3.8 2.488 0.090
Immature oocytes 4.1±2.7 2.7±2.6 1.5±2.3 3.971 0.023
Number of embryo 3.9±1.3 3.6±1.6 2.9±1.6 1.781 0.176
All values are expressed as mean ±SD.
P- value less than 0.05 was considered for statistical significance
P- value more than 0.05 was not considered for statistical significance
Fig.-1. Correlation between women age and the number of
mature oocyte.
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According to the number of oocytes retrieved upon
stimulation by menotrophin (FSH 75IU, LH 75 IU), the study
population was divided into poor, normal, good and high
responders (Table II). Fifteen (20%), 21 (28%), 32 (42.7%)
and 7 (9.3%) women gave <4, 4-8, 9-16 and >16 oocytes
during ovarian stimulation of IVF program, respectively.
When related to women age, the total number of oocytes
was generally increased with decreased age, showing <4, 4-
8, 9-16 and >16 oocytes at mean ages of 33.4±6.5, 30.2±4.5,
26.7±5.0 and 27.7±4.9 years, respectively. This inverse
relationship between the total number of oocytes and age
was found to be significant (F=6.773 and P=0.001), implying
that younger women yield more oocytes.
Table III shows the  relationship between women age and
IVF outcome. Positive pregnancy occurred in women aged
26.7±4.1 years whereas negative pregnancy and no cleavage
occurred at ages 30.6±6.4 and 32.0±4.2 years, respectively.
When related to women age, IVF outcome showed that the
chance of getting pregnant increased with decreased age
(F=4.278 and p= 0.018).
Table III
Age of the study population in relation to IVF outcome
during IVF program (n=75)
IVF outcome Age (year) F P-value
(mean ± SD)
Positive** 26.7±4.1 4.278 0.018
Negative*** 30.6±6.4
No cleavage 32.0±4.2
All values are expressed as mean ±SD.
P- value less than 0.05 was considered for statistical significance.
F: ANOVA test.
Positive: pregnancy occurred, Negative: no pregnancy.
Discussion
The results of this study indicated that the majority of women
in the Gaza Strip seeking IVF when their husbands had
fertility problems and the process of pregnancy is delayed.
A total 75 women was enrolled in IVF programs. The mean
age of women (29.2 years) was close to that reported in
Egyptian (29.0 years), Iranian (29.1 years) and Palestinian
(28.7 years) studies,13,15,16 but lower than that reported from
the USA and South Korea (34.0 years).17,18  The younger
women seeking IVF in developing countries, including Gaza
Strip, could be explained in the context of social habits where
most families have the desire to have children immediately
after marriage and they encourage women to undergo IVF.
This is supported by the finding that around half of the
study population had undergone repeated IVF. The outcome
of IVF was positive in 36.0% of the study population. This
finding was in agreement with the results of studies from the
Netherlands and South Korea which showed that 36.0% and
32.5% of women undergoing IVF achieved viable
pregnancy.17,19 However, the pregnancy rate among patients
who had an IVF trial in different settings was 23.1%.
Nevertheless, IVF treatment outcome is highly variable and
difficult to predict.15
Data of the present study revealed an inverse relationship
between women age and various types of oocytes, and
embryo, with significant change detected with the total
number of retrieved oocytes. Similar results were
obtained.3,13,17,20 Such decrease in the total number of
oocytes with aging may be related to increase basal level of
FSH which results in diminishing ovarian reserve and to the
responsiveness of women in IVF program.21,22 In this context,
Pearson correlation test showed negative significant
correlation between age and the number of mature oocyte.
This result is in concurrent with that previously reported.13,20
Ovarian response was diminished with aging, showing
poor response (<4 oocytes) at the mean age of 33.4±6.5
Table II
Age of the study population in relation to ovarian response during IVF program (n=75)
Ovarian response No. (%) Age (year) (mean ± SD) F P-value
Poor responders(<4 oocytes) 15 20 33.4±6.5 6.773 0.001
Normal responders(4-8 oocytes) 21 28 30.2±4.5
Good responders(9-16 oocytes) 32 42.7 26.7±5.0
High responders(>16 oocytes) 7 9.3 27.7±4.9
All values are expressed as mean ±SD.
P- value less than 0.05 was considered for statistical significance.
F: ANOVA test.
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years and good response (9-16 oocytes) at the mean age of
26.7±5.02 years. This means that younger women have a
better chance of a successful IVF. Studies carried out on
ovarian reserve and ovarian response in IVF women found
that the poor responses were detected at mean ages 36.3
and 32.5 years23, 24. This inverse relationship between
ovarian response and female age was also documented in
other studies.13,16,20 The IVF outcome showed that the
youngest women (mean age 26.7±4.1 years) had a better
opportunity to get pregnant. This is supported by the
aforementioned finding that ovarian response increased
with decreasing age making more chance for pregnancy to
occur. In addition, this finding coincides with other studies
who found that pregnancy outcome of IVF program was
significantly higher in younger women than that in the
older ones.13,25 Similar findings were also reported,19 but
the difference in the pregnancy outcome of IVF program
was not significant.
Conclusion
In conclusion, the total number of retrieved oocytes, ovarian
response and the chance of getting pregnancy were
diminishing with ageing. Therefore, it is important to consider
maternal age during IVF program.
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